SCHEMBL30450449

SCHEMBL30450449

CC(C)(C)OC(=O)N1CCCCC1Nc1ncc(C(F)(F)F)c(-c2c[nH]cn2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 11/20 0.39
▸ CCNE1 P24864 10/20 0.39
▸ CCNK O75909 6/20 0.38
▸ CDK12 Q9NYV4 6/20 0.38
▸ CCNT1 O60563 5/20 0.38
▸ CDK9 P50750 5/20 0.38
▸ ALK Q9UM73 2/20 0.38
▸ CDK7 P50613 4/20 0.36
▸ CCNH P51946 4/20 0.36
▸ MNAT1 P51948 4/20 0.36
▸ CDK1 P06493 3/20 0.36
▸ CDK4 P11802 3/20 0.36
▸ CCNB1 P14635 3/20 0.36
▸ CCND1 P24385 3/20 0.36
▸ CCND3 P30281 3/20 0.36
▸ CDK6 Q00534 3/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ WNT3 P56703 2/20 0.34
▸ SFRP1 Q8N474 2/20 0.34
▸ CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22977511 0.84 IDH1 (0.48) CDK2CCNE1CCNT1CDK9ALK
SCHEMBL30449867 0.82 ALK (0.41) ALKTRPV1WNT3SFRP1
SCHEMBL22997632 0.81 CDK4 (0.43) CDK2CCNE1CCNKCDK12CCNT1
SCHEMBL22997627 0.81 CDK4 (0.43) CDK2CCNE1CCNKCDK12CCNT1
SCHEMBL22983953 0.74 CCNE1 (0.50) CDK2CCNE1CCNKCDK12CCNT1
SCHEMBL22977388 0.74 CCNE1 (0.40) CDK2CCNE1CCNKCDK12CCNT1
SCHEMBL30449440 0.74 ALK (0.41) CDK2CCNKCDK9ALKCDK4
SCHEMBL22977357 0.72 CCNE1 (0.72) CDK2CCNE1CCNT1CDK9CDK7
SCHEMBL29820627 0.72 CCNE1 (0.72) CDK2CCNE1CCNT1CDK9CDK7
SCHEMBL29091778 0.71 GPR119 (0.46) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116348458-A Imidazolylpyrimidinylamine compounds as CDK2 inhibitors 因赛特公司 2023-06-27 — — CN disclosed
Send feedback